TOP

Needle-Trap for Nipro: Needle Protection for Vaccine Syringes

SCHREINER MEDIPHARM

Needle-Trap for Nipro: Needle Protection for Vaccine Syringes

To enhance safety of injection for both healthcare professionals and patients, Schreiner MediPharm developed its Needle-Trap needle protection system more than ten years ago. Since then, Needle-Trap has become successfully established in the marketplace. Extensive tests determine the compatibility of the system with specific syringes. Nipro PharmaPackaging has undergone these tests in order to extend its portfolio of safety systems for glass syringes and successfully passed them: Needle-Trap is fully compatible with Nipro’s D2F™pre-fillable glass syringes for vaccines.

The vaccine syringes are designed specifically for simple and safe vaccinations. The pre-fillable glass syringes are available in different sizes and a wide variety of needle configurations and accessories. Needle-Trap is a label with an integrated safety mechanism as protection against needlestick injuries after an injection has been performed. The needle protection system is activated by placing the needle trap on a firm surface using one hand and pushing the syringe needle into the trap. A perceptible click confirms that the needle has locked into the trap and thus been secured.

The compatibility tests of Needle-Trap and Nipros D2F™ pre-fillable glass syringes were conducted at the research and development laboratories at Schreiner Group’s headquarters in Oberschleissheim and investigated the functionality of Needle-Trap on syringes with varying cylinder sizes (0.5 ml and 1 ml in length) and hypodermic needle sizes (27G NW, 27G TW and 29G TW).

The outcome convinced Nipro: All tests with Needle-Trap labels applied to the various syringe types produced positive results and consistently demonstrated a reliable activation of the protective mechanism. In each test, the syringe needle was safely and clearly perceptibly secured in the integrated needle trap.

About Nipro

Nipro PharmaPackaging is part of Nipro Corporation Japan, established in 1954. As a leading global healthcare company with over 33.000 employees worldwide, Nipro serves the Pharmaceutical, Medical Device, and Pharma Packaging industries. Nipro PharmaPackaging is specialized in developing and manufacturing advanced pharma packaging products and complete packaging solutions for early development drugs or the enhancement of packaging solutions for existing drugs. With a worldwide manufacturing footprint of 14 plants, multiple sales offices, and internal lab services, Nipro PharmaPackaging offers an exceptional service platform. Through our personnel, products, and services, Nipro PharmaPackaging enables you to provide a safer and healthier administration to your customers. https://www.nipro-group.com/en